Exemplis Discimus 2005, 149(1):75-82

Etiam neque urna, sollicitudin et, hendrerit et, porta ac, mi.

Dasead Sedayaa, Vella Tachia, Melanah Anjeka,b, Nesota Homanlifa,c, Edvar Aneza, Varina Janina, Asori Alucarda
a Department of Anatomy, Teaching Hospital of Hypori, Republic of Bespin
b 2nd Clinic of Venereology, University Hospital of Coruscant, Republic of Anoat
c 1st Clinic of Medical Biotechnology, University of Antemeridian, Republic of Subterrel

Nulla leo turpis, luctus ac, suscipit vitae, condimentum vel, neque. Suspendisse nibh nisl, iaculis non, rutrum fringilla, viverra bibendum, lacus. Praesent eros pede, vestibulum in, molestie suscipit, faucibus et, arcu. Pellentesque sed dolor ut diam scelerisque eleifend. Mauris ligula eros, condimentum vel, malesuada ac, sollicitudin in, urna. Curabitur risus arcu, fermentum eu, consectetuer ut, tempus nec, lorem. Praesent nunc leo, bibendum at, volutpat eget, mattis vitae, tortor. Donec quis elit eu massa fringilla faucibus.

Klíčová slova: Vivamus neque, Ut sit amet nulla, Nam euismod, Suspendisse potenti, Phasellus massa, Sed quis tellus, Cras ac odio, Integer est

Vloženo: 10. květen 2005; Přijato: 7. červen 2005; Zveřejněno: 1. červenec 2005 

Zobrazit celý článek

Reference

  1. Bajgar J. (1992) Biological monitoring of exposure to nerve agents. Brit J Ind Med 49, 648-53.
  2. Bajgar J. (2004) Organophosphates/nerve agents poisoning: mechanism of action, diagnosis, prophylaxis and treatment. Adv Clin Chem 38, 151-216. Přejít k původnímu zdroji... Přejít na PubMed...
  3. Bajgar J. (1998) Cholinesterases and their possible influencing. Voj Zdrav Listy 67, 1-6.
  4. Zajtchuk R, Bellamy RF. Medical aspects of chemical and biological warfare. Office of the Surgeon General: Department of the Army, United states of America, 1997.
  5. Yokoyama K, Araki S, Murata K, Nishikitami M, Okomura T, Ishimatsu S, Takasu M. (1998) Chronic neurobehavioral and central autonomic nervous system effects in Tokyo subway sarin poisoning. J Physiol 92, 317-23.
  6. Tucker JB. Evidence Iraq used chemical waepons during the 1991 Persian Gulf War. The Nonproliferation Review: Spring-Summer 1997, pp 114-122. Přejít k původnímu zdroji...
  7. Marrs TC. (1993) Organophosphate poisoning. Pharmacol Therap 58, 51-66. Přejít k původnímu zdroji... Přejít na PubMed...
  8. Taylor P. Anticholinergic agents. The Pharmacological Basis of Therapeutics. McGraw Hill: New York, 1996.
  9. Bajgar J. (1994) The influence of inhibitors and other factors on cholinesterases. Sb Ved Praci LFUK (Hradec Kralove) 34, 3-77.
  10. Kassa J. (2002) Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40, 803-16. Přejít k původnímu zdroji... Přejít na PubMed...
  11. Kuča K, Patočka J, Cabal J. (2003) Reactivation of organophosphate inhibited acetylcholinesterase activity by ,-bis-(4-hydroxy iminomethylpyridinium)alkanes in vitro. J Appl Biomed 1, 207- 11.
  12. Bielavský J, Kassa J, Elsnerová I, Dejmek L. (1997) Cholinesterase reactivators derived from pyridine-2-carbaldoxime, Collect Czech Chem Commun 63, 199-204. Přejít k původnímu zdroji...
  13. Cabal J, Bajgar J. (1999) Tabun - Reappearance 50 years later. Chemicke Listy 93, 27-9. (in Czech)
  14. Kuča K, Bielavský J, Cabal J, Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase-1-(4-hydroxyiminomethylpyridinium)- 3-(carbamoylpyridinium) -propane dibromide. (2003) Tetrahedron Lett 44, 3123-25.
  15. Kuča K, Bielavský J, Cabal J, Kassa J. (2003) Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 13, 3545-7. Přejít k původnímu zdroji... Přejít na PubMed...
  16. Kuča K, Cabal J, Patočka J, Kassa J. (2004) Synthesis of bisquaternary symmetric - ,-bis(2-hydroxyiminomethylpyridinium)alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett Org Chem 1, 84-6. Přejít k původnímu zdroji...
  17. Kuča K, Kassa J. (2003) A comparison of the ability of a new byispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4- carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem 18, 529-35. Přejít k původnímu zdroji... Přejít na PubMed...
  18. Kuča K, Kassa J. (2004) In vitro reactivation of acetylcholinesterase using the oxime K027. Vet Hum Toxicol 46, 15-8. Přejít na PubMed...
  19. Kuča K, Dohnal V. (2004) 1,3-bis(2-hydroxyiminomethylpyridinium) propane as the potential reactivator of the acetylcholinesterase inhibited by nerve agents. Acta Medica (Hradec Kralove) 47, 167-9. Přejít na PubMed...
  20. Kuča K, Cabal J, Kassa J. (2004) A comparison of the efficacy of a bispyridinium oxime-1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Pharmazie 59, 795-8. Přejít na PubMed...
  21. Patočka J, Bielavský J, Ornst F. (1970) Reactivating effect of alpha,omega-bis-(4-pyridinealdoxime)-2-trans-butene dibromide on isopropyl-methylphosphonylated acetylcholinesterase. FEBS Lett 10, 182-4. Přejít k původnímu zdroji... Přejít na PubMed...
  22. Patočka J, Bielavský J. (1972) Affinity of bis-quaternary pyridinealdoximes for the active centre of intact and isopropylmethylphosphonylated acetylcholinesterase. Coll Czech Chem Commun 37, 2110-6. Přejít k původnímu zdroji...
  23. Kuča K, Patočka J. (2004) Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enzyme Inhib Med Chem 19, 39-43. Přejít k původnímu zdroji... Přejít na PubMed...
  24. Kassa J, Cabal J. (1999) A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84, 41-5. Přejít na PubMed...
  25. Kassa J, Cabal J. (1999) A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 18, 560-5. Přejít k původnímu zdroji... Přejít na PubMed...
  26. Kassa J, Cabal J. (1999) A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132, 111-8. Přejít k původnímu zdroji... Přejít na PubMed...
  27. Worek F, Reiter G, Eyer P, Szinicz L. (2002) Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 76, 523-9. Přejít k původnímu zdroji... Přejít na PubMed...
  28. Kuča K, Pícha J, Cabal J, Liška F. (2004) Synthesis of the three monopyridinium oximes and evaluation of their potency to reactivate acetylcholinesterase inhibited by nerve agents. J Appl Biomed 2, 51-6.
  29. Tallarida R, Murray R. Manual of Pharmacological Calculation with Computer Programs. Springer-Verlag: New York 1987.
  30. Kuča K, Cabal J. (2003) An in vitro comparison of the reactivator efficacy of potential symmetric bisquaternary acetylcholinesterase reactivators which differ in their connecting chain length. Voj Zdrav Listy 72, 129-31 (in Czech).
  31. Ševelová L, Vachek J. (2003) Effect of methoxime combined with anticholinergic, anticonvulsant or anti-HCN drugs in tabun-poisoned mice. Acta Medica (Hradec Kralove) 46, 109-12. Přejít na PubMed...
  32. Ševelová L, Kuča K, Krejčová-Kunešová G. (2004) Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes. Toxicology 207, 1-6. Přejít k původnímu zdroji... Přejít na PubMed...
  33. Ševelová L, Kuča K, Krejčová G, Vachek J. (2004) Therapeutic efficacy of oxime treatment in cyclosarin-poisoned mice pretreated with combination of pyridostigmine, benactyzine and trihexyphenidyl. J Appl Biomed 2, 163-7.

Zpět na obsah